Melexis NV shares fell sharply on Wednesday, dropping 7.6% to trade at EUR 71.95 after Deutsche Bank reclassified the Belgian automotive semiconductor specialist from Buy to Hold.
Deutsche Bank analyst Robert Sanders outlined several headwinds he sees across the technology hardware sector. His list of concerns included uncertainty about AI monetization, slower-than-expected enterprise uptake of new technologies, the distortions that can arise from component shortage-driven double ordering, strains on power grids, and the risk of cutbacks in hyperscaler capital expenditure. Sanders said these factors together justified a more cautious rating on Melexis.
Interestingly, the bank raised its price target for Melexis to EUR 75 from EUR 65 at the same time, but the change in sentiment from Buy to Hold had a larger market effect. With the stock having climbed roughly 39% over the prior three months and opening today at EUR 74.50 - already close to the newly set target - many investors saw limited potential for further gains under the updated analyst outlook. That alignment encouraged profit-taking that pushed the shares to a session low of EUR 71.80.
The share movement was notable against a positive broader market backdrop. U.S. benchmarks advanced during the session, with the S&P 500 rising 0.8% and the Nasdaq gaining 1.3%. Melexis’s performance diverged markedly from this strength.
Peers in the sector did not register material company-specific news that could explain the drop. Both STMicroelectronics and Infineon Technologies were mentioned as key sector comparables, and since neither released notable updates today, the Deutsche Bank action appears to be the primary idiosyncratic driver behind Melexis’s pronounced underperformance.
Investors may also be mindful of the company’s calendar: Melexis’s next scheduled earnings announcement is set for July 29, 2026, a date that could contribute to caution among some holders ahead of new fundamental data.
Taken together, the sequence of a high-profile analyst downgrade arriving after a significant rally - coupled with a revised price target that offered limited upside from recent trading levels - created the conditions for the outsized one-day decline. The shares remain well above their 52-week low of EUR 48.60, but the drop pulls them back from a 52-week high of EUR 86.70, illustrating how quickly investor sentiment can change when a major institutional voice shifts to neutral.
Key metrics cited in the market action include the 7.6% intraday slide to EUR 71.95, the raised target to EUR 75 from EUR 65, the roughly 39% advance over the prior three months, today’s opening level of EUR 74.50, and a session low of EUR 71.80. Those figures framed investor reactions in a trading session otherwise characterized by gains for U.S. indexes.
For now, the Deutsche Bank downgrade stands out as the proximate cause of Melexis’s sudden weakness, while the upcoming earnings date and the structural and cyclical risks flagged by the analyst may keep investors cautious until fresh company-level data becomes available.